Yüklüyor......
Cytokine release syndrome: grading, modeling, and new therapy
Genetically modified T cells that express a chimeric antigen receptor (CAR) are opening a new frontier in cancer immunotherapy. CAR T cells currently are in clinical trials for many cancer types. Cytokine release syndrome (CRS) and neurotoxicities (CAR-related encephalopathy syndrome, CRES) are majo...
Kaydedildi:
| Yayımlandı: | J Hematol Oncol |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BioMed Central
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6154787/ https://ncbi.nlm.nih.gov/pubmed/30249264 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-018-0653-x |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|